These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1370604)
1. Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Zauli G; Re MC; Visani G; Furlini G; La Placa M Arch Virol; 1992; 122(3-4):271-80. PubMed ID: 1370604 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells). Zauli G; Re MC; Furlini G; Giovannini M; La Placa M J Gen Virol; 1992 Feb; 73 ( Pt 2)():417-21. PubMed ID: 1371543 [TBL] [Abstract][Full Text] [Related]
3. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Sugiura K; Oyaizu N; Pahwa R; Kalyanaraman VS; Pahwa S Blood; 1992 Sep; 80(6):1463-9. PubMed ID: 1520872 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. Maciejewski JP; Weichold FF; Young NS J Immunol; 1994 Nov; 153(9):4303-10. PubMed ID: 7523521 [TBL] [Abstract][Full Text] [Related]
5. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins. Neurath AR; Strick N; Li YY; Jiang S AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138 [TBL] [Abstract][Full Text] [Related]
6. Evidence for an HIV-1 mediated suppression of in vitro growth of enriched (CD34+) hematopoietic progenitors. Zauli G; Re MC; Furlini G; Giovannini M; La Placa M J Acquir Immune Defic Syndr (1988); 1991; 4(12):1251-3. PubMed ID: 1719189 [TBL] [Abstract][Full Text] [Related]
7. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells. Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435 [TBL] [Abstract][Full Text] [Related]
8. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. Raja NU; Vincent MJ; Jabbar MA J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500 [TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in the promoting effect of HIV type 1 infection and of gp120 envelope glycoprotein on interleukin 4-induced IgE production by normal human mononuclear cells. Dugas N; Dereuddre-Bosquet N; Goujard C; Dormont D; Tardieu M; Delfraissy JF AIDS Res Hum Retroviruses; 2000 Feb; 16(3):251-8. PubMed ID: 10710213 [TBL] [Abstract][Full Text] [Related]
12. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors. Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479 [TBL] [Abstract][Full Text] [Related]
13. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing. Koga Y; Nakamura K; Sasaki M; Kimura G; Nomoto K Virology; 1994 May; 201(1):137-41. PubMed ID: 8178478 [TBL] [Abstract][Full Text] [Related]
14. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins. Tani Y; Tian H; Lane HC; Cohen DI J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106 [TBL] [Abstract][Full Text] [Related]
15. The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Re MC; Zauli G; Furlini G; Ranieri S; Monari P; Ramazzotti E; La Placa M Arch Virol; 1993; 129(1-4):53-64. PubMed ID: 7682405 [TBL] [Abstract][Full Text] [Related]
16. [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis]. Chen Y; Garcia R; Baralle FE Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):120-6. PubMed ID: 10453506 [TBL] [Abstract][Full Text] [Related]
17. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells. Rodriguez D; Rodriguez JR; Esteban M AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199 [TBL] [Abstract][Full Text] [Related]
18. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing. Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096 [TBL] [Abstract][Full Text] [Related]
19. Secondary structure of gp160 and gp120 envelope glycoproteins of human immunodeficiency virus type 1: a Fourier transform infrared spectroscopic study. Decroly E; Cornet B; Martin I; Ruysschaert JM; Vandenbranden M J Virol; 1993 Jun; 67(6):3552-60. PubMed ID: 8497064 [TBL] [Abstract][Full Text] [Related]
20. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum. Kimura T; Nishikawa M; Ohyama A J Biochem; 1994 May; 115(5):1010-20. PubMed ID: 7961587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]